The UK government has announced a novel initiative trial to offer weight loss medication Mounjaro to people with obesity who are unemployed, to improve their health and help them re-enter the workforce, said British Health Minister Wes Streeting said on Tuesday. The trial is part of a broader NHS strategy that offers weight-loss medication to 3,000 participants over five years.
The manufacturer of the drug Eli Lilly announced on Monday that it will commit £279 million ($364 million) to help deal with Britain’s significant health challenges, including obesity.
